Original: $229.00
-70%$229.00
$68.70The Story
ā¢ Composition and format
Brain Blend - Dihexa (10 mg) / Tesofensine (250 mcg) / BPC-157 (125 mcg) x 60 Tablets is a fixed-combination research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 10 mg of Dihexa, 250 mcg of Tesofensine, and 125 mcg of BPC-157, with 60 tablets per container. The batch-specific Certificate of Analysis (COA) details compound identities, per-unit content, physical form, and relevant excipient information, supporting method-level reproducibility, mass-balance calculations, and documentation control in research settings.
ā¢ Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
ā¢ Intended research use
This Brain Blend is evaluated in controlled in-vitro systems investigating multi-target signaling, including neuroactive pathway models, energy-balance-related neurotransmitter systems, and peptide-mediated cell-communication networks, as well as pathway mapping in complex assay designs. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
ā¢ Research characteristics and applications
This combination of Dihexa, Tesofensine, and BPC-157 is characterized for use as a multi-analyte research reagent in analytical and cell-based models. Researchers employ the blend in defined in-vitro environments to examine concentration-response relationships, receptor and transporter engagement, downstream signaling cascades, and interaction networks among neuroactive and peptide pathways. Applications include comparative pathway profiling, assay development, and systems-level mapping of molecular feedback loops under controlled laboratory conditions only.
ā¢ Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
Research Use Only (RUO) Statement
ā¢ For in-vitro research only
ā¢ Not for human or animal consumption
ā¢ Not for diagnostic or therapeutic use
Description
ā¢ Composition and format
Brain Blend - Dihexa (10 mg) / Tesofensine (250 mcg) / BPC-157 (125 mcg) x 60 Tablets is a fixed-combination research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 10 mg of Dihexa, 250 mcg of Tesofensine, and 125 mcg of BPC-157, with 60 tablets per container. The batch-specific Certificate of Analysis (COA) details compound identities, per-unit content, physical form, and relevant excipient information, supporting method-level reproducibility, mass-balance calculations, and documentation control in research settings.
ā¢ Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
ā¢ Intended research use
This Brain Blend is evaluated in controlled in-vitro systems investigating multi-target signaling, including neuroactive pathway models, energy-balance-related neurotransmitter systems, and peptide-mediated cell-communication networks, as well as pathway mapping in complex assay designs. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
ā¢ Research characteristics and applications
This combination of Dihexa, Tesofensine, and BPC-157 is characterized for use as a multi-analyte research reagent in analytical and cell-based models. Researchers employ the blend in defined in-vitro environments to examine concentration-response relationships, receptor and transporter engagement, downstream signaling cascades, and interaction networks among neuroactive and peptide pathways. Applications include comparative pathway profiling, assay development, and systems-level mapping of molecular feedback loops under controlled laboratory conditions only.
ā¢ Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
Research Use Only (RUO) Statement
ā¢ For in-vitro research only
ā¢ Not for human or animal consumption
ā¢ Not for diagnostic or therapeutic use
